The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Issam Zineh

Center for Pharmacogenomics and Department of Pharmacy Practice

University of Florida College of Pharmacy

Gainesville

Florida

United States of America

[email]@cop.ufl.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Center for Pharmacogenomics and Department of Pharmacy Practice, University of Florida College of Pharmacy, Gainesville, Florida, United States of America. 2008
  • University of Florida College of Pharmacy, Department of Pharmacy Practice and Center for Pharmacogenomics, Gainesville, FL 32610, USA. 2005 - 2007
  • Department of Pharmacy Practice, College of Pharmacy, University of Florida, P.O. Box 100486, USA. 2003 - 2006

References

  1. Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins. Zineh, I., Beitelshees, A.L., Welder, G.J., Hou, W., Chegini, N., Wu, J., Cresci, S., Province, M.A., Spertus, J.A. PLoS. ONE (2008) [Pubmed]
  2. Pharmacogenetics of response to statins. Zineh, I. Curr. Atheroscler. Rep (2007) [Pubmed]
  3. CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78). Zineh, I., Aquilante, C.L., Langaee, T.Y., Beitelshees, A.L., Arant, C.B., Wessel, T.R., Schofield, R.S. Cytokine (2006) [Pubmed]
  4. Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors. Zineh, I., Luo, X., Welder, G.J., Debella, A.E., Wessel, T.R., Arant, C.B., Schofield, R.S., Chegini, N. Pharmacotherapy (2006) [Pubmed]
  5. Development and cross-validation of sequencing-based assays for genotyping common polymorphisms of the CXCL5 gene. Zineh, I., Welder, G.J., Langaee, T.Y. Clin. Chim. Acta (2006) [Pubmed]
  6. Discordance between availability of pharmacogenetics studies and pharmacogenetics-based prescribing information for the top 200 drugs. Zineh, I., Pebanco, G.D., Aquilante, C.L., Gerhard, T., Beitelshees, A.L., Beasley, B.N., Hartzema, A.G. Ann. Pharmacother (2006) [Pubmed]
  7. Pharmacogenetics of chronic cardiovascular drugs: applications and implications. Zineh, I., Johnson, J.A. Expert. Opin. Pharmacother (2006) [Pubmed]
  8. Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot study. Zineh, I., Welder, G.J., DeBella, A.E., Arant, C.B., Wessel, T.R., Schofield, R.S. Pharmacotherapy (2006) [Pubmed]
  9. Complementary and alternative medicine use among individuals participating in research: implications for research and practice. Welder, G.J., Wessel, T.R., Arant, C.B., Schofield, R.S., Zineh, I. Pharmacotherapy (2006) [Pubmed]
  10. HMG-CoA reductase inhibitor pharmacogenomics: overview and implications for practice. Zineh, I. Future. Cardiol (2005) [Pubmed]
  11. Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs. Zineh, I., Gerhard, T., Aquilante, C.L., Beitelshees, A.L., Beasley, B.N., Hartzema, A.G. Pharmacogenomics J. (2004) [Pubmed]
  12. The evolving role of nesiritide in advanced or decompensated heart failure. Zineh, I., Schofield, R.S., Johnson, J.A. Pharmacotherapy (2003) [Pubmed]
 
WikiGenes - Universities